Literature DB >> 16230737

The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ken Shinmura, Roberto Bolli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230737     DOI: 10.7326/0003-4819-143-8-200510180-00022

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

Review 1.  Preconditioning: a paradigm shift in the biology of myocardial ischemia.

Authors:  Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

Review 2.  The late phase of preconditioning and its natural clinical application--gene therapy.

Authors:  Roberto Bolli; Qian-Hong Li; Xian-Liang Tang; Yiru Guo; Yu-Ting Xuan; Gregg Rokosh; Buddhadeb Dawn
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.